Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/1862
Full metadata record
DC FieldValueLanguage
dc.contributor.authorOKONTA, Emeka M-
dc.date.accessioned2024-06-13T08:28:06Z-
dc.date.available2024-06-13T08:28:06Z-
dc.date.issued2020-09-25-
dc.identifier.issn2468-7391-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/1862-
dc.description.abstractThe coronavirus disease also known as COVID‑19 was discovered at the end of 2019 following epidemic of acute respiratory syndrome in humans in Wuhan, China. It leads to lung destruction at acute stage of the disease and, possibly, progressive lung destruction from extensive inflammatory process at the ground zero which is the lung. This will eventually lead to a permanent scaring of the lungs with reduction in the oxygenation of the lungs and eventually end‑stage lung disease. The use of ventilations and extracorporeal membrane oxygenation does not seem to hold the ace in guaranteeing a long‑term relieve, but lung transplant for the condition may be the solution in a long‑term basis.en_US
dc.language.isoenen_US
dc.publisherNIGERIAN JOURNAL OF CARDIOVASCULAR AND THORACIC SURGERYen_US
dc.relation.ispartofseriesVolume 4;No 2-
dc.subjectCOVID-19en_US
dc.subjectTransplanten_US
dc.subjectLungsen_US
dc.titleLUNG TRANSPLANT AFTER COVID-19, WOULD THERE BE A NEED FOR IT IN THE FUTUREen_US
dc.typeArticleen_US
Appears in Collections:Books

Files in This Item:
File Description SizeFormat 
55LungtransplantandCOVID-19-2.pdf1.12 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.